CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
Abstract Background The CEACAM family, a major subgroup of the carcinoembryonic antigen (CEA) family, is widely expressed in normal and neoplastic tissues. Although CEACAM6 overexpression has been reported in cholangiocarcinoma (CCA), the molecular mechanisms by which it modulates chemosensitivity i...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2026-02-01
|
| Saila: | Clinical and Translational Discovery |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/ctd2.70126 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|